These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Spectrum of erythrocyte membrane lipids in various types of hypoglycemic therapy].
    Author: Kozlov GS, Buĭdina TA, Balabolkin MI.
    Journal: Sov Med; 1990; (6):10-3. PubMed ID: 2396109.
    Abstract:
    Changes in the lipid spectrum of red cell membrane (cholesterol, total and fractional phospholipids) were examined in 46 patients with newly detected non-insulin-dependent diabetes mellitus at the period of the disease diagnosis and over the course of therapy with various sugar-reducing drugs. Diabeton, a gliclazide series drug, has shown the most manifest compensatory effect on red cell membrane lipid shifts. Diets and biguanide therapy for 6-8 months failed to stably normalize the detected shifts; further correction appeared to be necessary in such cases.
    [Abstract] [Full Text] [Related] [New Search]